Eagle Pharmaceuticals (EGRX) Earnings
|
Expand Research on EGRX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +2.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -9.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/9/26  |
Q425 | N/A | N/A | N/A | N/A | $55.05M | N/A | N/A | N/A | ||
| 11/24/25 |
Q325 | N/A | N/A | N/A | N/A | $54.09M | N/A | N/A | N/A | ||
| 11/20/25 |
Q325 | N/A | N/A | N/A | N/A | $54.09M | N/A | N/A | N/A | ||
| 11/18/25 |
Q325 | N/A | N/A | N/A | N/A | $54.09M | N/A | N/A | N/A | ||
| 11/17/25 |
Q325 | N/A | N/A | N/A | N/A | $54.09M | N/A | N/A | N/A | ||
| 11/14/25 |
Q325 | N/A | N/A | N/A | N/A | $54.09M | N/A | N/A | N/A | ||
| 11/12/25 |
Q325 | N/A | N/A | N/A | N/A | $54.09M | N/A | N/A | N/A | ||
| 11/11/25 |
Q325 | N/A | N/A | N/A | N/A | $54.09M | N/A | N/A | N/A |
